Enliven Therapeutics, Inc. 10-Q

Accession 0001193125-25-277619

Filing information

CIK: 0001672619
Report date: 2025-09-30
Filing date: 2025-11-12
Form: 10-Q
Primary document: elvn-20250930.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.